Real-World Experience to Understand the Usage of Sebamed® Antibacterial Cleansing Foam in the Prevention of Acne

Background: Acne vulgaris is a common condition affecting millions globally, with a high prevalence during puberty. Adult-onset acne, particularly in women, is on the rise. Treatment focuses on sebum control and improving appearance, but adherence poses challenges. Aim and objective: This study aimed to assess the effectiveness of Sebamed® antibacterial cleansing foam in preventing acne in real-world settings in India. Methods: This study was a retrospective, multi-centric observational study conducted in 51 Indian healthcare centres. It focused on adult patients with acne vulgaris treated with Sebamed® antibacterial cleansing foam. The study included adult patients of either sex with mild-to-moderate acne or a propensity to develop acne without known allergies or sensitivities to cosmetic products. Results: In this retrospective analysis of 486 patients, the majority had moderate to severe acne (Grade 2 and Grade 3). Most patients had oily skin (47.9%) and facial acne (92.5%). Sebamed® patients with different grades of acne preferred antibacterial cleansing foam and the median duration of treatment was 2 months. Most patients used the foam twice a day and substantial improvement was observed in 56.4%, with a complete resolution of acne in 3.5%. Most patients experienced better to much better efficacy outcomes in different acne parameters, including oiliness (92.2%), papules (90.7%), pustules (86.3%), nodules (82.1%), open comedones (81.9%) and closed comedones (77.2%). Side effects were observed in 2.5% of patients. Conclusion: Sebamed® antibacterial cleansing foam shows promising effectiveness and tolerability as a treatment for acne vulgaris. Further research is needed to validate these findings in larger populations.